Author: Groeneveld, Geert H; van der Reyden, Tanny J; Joosten, Simone A; Bootsma, Hester J; Cobbaert, Christa M; de Vries, Jutte J C; Kuijper, Ed J; van Dissel, Jaap T
Title: Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial Document date: 2019_5_18
ID: 19ueli6e_34
Snippet: Between January 2013 and May 2014, a total of 41 patients with community-acquired pneumonia were included. After the empirical start of antibiotic treatment in all study patients, 17 of them were found to have pneumococcal pneumonia. Of these 17 patients, 13 were in the intervention group and 4 were in the control group. In these 13 patients, 10 completed the 48 h (four dosages) of rifampicin treatment, 2 received three dosages and 1 received two.....
Document: Between January 2013 and May 2014, a total of 41 patients with community-acquired pneumonia were included. After the empirical start of antibiotic treatment in all study patients, 17 of them were found to have pneumococcal pneumonia. Of these 17 patients, 13 were in the intervention group and 4 were in the control group. In these 13 patients, 10 completed the 48 h (four dosages) of rifampicin treatment, 2 received three dosages and 1 received two dosages. The median number of infected lobes was one.
Search related documents:
Co phrase search for related documents- antibiotic treatment and intervention group: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antibiotic treatment and median number: 1, 2, 3
- antibiotic treatment and pneumococcal pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antibiotic treatment and rifampicin treatment: 1, 2, 3, 4, 5, 6, 7, 8
- antibiotic treatment and study patient: 1, 2, 3, 4, 5, 6
- control group and dosage receive: 1
- control group and intervention group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- control group and median number: 1, 2, 3, 4, 5, 6, 7, 8
- control group and pneumococcal pneumonia: 1, 2
- control group and rifampicin treatment: 1, 2, 3
- control group and study patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- dosage receive and intervention group: 1, 2, 3
- intervention group and median number: 1
- intervention group and pneumococcal pneumonia: 1
- intervention group and rifampicin treatment: 1, 2, 3
- intervention group and study patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- median number and study patient: 1, 2, 3, 4, 5, 6, 7, 8
- pneumococcal pneumonia and rifampicin treatment: 1, 2, 3, 4, 5, 6, 7
- pneumococcal pneumonia and study patient: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date